Lataa...
A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Objective: Methylphenidate (MPH) is efficacious in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD), but there are no data about the efficacy and safety of its new formulation (ORADUR(®)-MPH extended release, ORADUR-MPH) in patients with ADHD, which is the study objective. Method...
Tallennettuna:
| Julkaisussa: | J Child Adolesc Psychopharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mary Ann Liebert, Inc., publishers
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8066345/ https://ncbi.nlm.nih.gov/pubmed/33395356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2020.0104 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|